Browse topics

Clinical guides / Cataract & IOL

Age-related cataract

Updated

At a glance

Lens opacity matters when it impairs visual function or prevents management of other eye disease.

CAVE [1][2]

  • Do not attribute disproportionate visual loss to a mild cataract.
  • Check the macula, optic nerve and ocular surface.

Clinical presentation [1]

  • Progressive blur, glare, reduced contrast, monocular diplopia or refractive change.

Diagnosis & investigations [1]

  • Record the functional complaint, best-corrected acuity/refraction, glare needs and realistic visual potential. Examine the surface, cornea, pupil, zonules, lens and dilated fundus; macular OCT when symptoms, examination or IOL choice require it.
  • Before biometry, stabilise dry eye. Record axial length and keratometry quality, prior corneal surgery, pseudoexfoliation/phacodonesis, poor dilation, alpha-blocker exposure, anticoagulants, diabetes and previous uveitis/retinal disease. Do not stop systemic drugs automatically; plan with the responsible clinician.

Differential diagnosis [1]

  • Macular disease, corneal irregularity, uncorrected refractive error and optic neuropathy.

Treatment [1]

  • Offer surgery when cataract-related limitations justify its risks, not at a fixed acuity threshold. Agree the refractive target and IOL before consent; plan support devices or senior surgery for zonular/pupillary risk.
  • Use ocular antisepsis and an evidence-based intracameral antibiotic protocol. ESCRS supports cefuroxime 1 mg in 0.1 mL at the end of surgery when appropriate; correct preparation and allergy assessment are essential. Postoperative anti-inflammatory treatment commonly combines topical steroid and NSAID, with attention to corneal disease and diabetic macular risk.

Follow-up [1][2]

  • Tailor early review to the operation and risk: complications, glaucoma, monocular status or unexpected symptoms favour direct early assessment. Check acuity, IOP, wound integrity, corneal clarity, chamber inflammation and IOL position. Provide a same-day contact route for pain or falling vision. Refraction and final visual outcome are assessed after stabilisation.
Unexpected postoperative findings [1][2]
FindingActionTiming / detail
Pain, reduced vision, hypopyon or marked inflammationExclude endophthalmitis urgently; assess vitreous, wound and fundus, with B-scan if neededSame-day surgical/retinal review; onset alone does not reliably distinguish TASS from infection
Corneal oedema or unexpectedly poor acuityCheck IOP, wound/Seidel, chamber depth, Descemet membrane and retained lens materialPainful high IOP or shallow chamber needs prompt treatment, not routine discharge
Low IOP or suspected wound leakExamine wound integrity and chamber; inform the operating teamA leak creates an infection risk; management depends on leak size and chamber stability
Later central blur/metamorphopsiaExamine macula with OCT for cystoid oedema; assess refraction, ocular surface and posterior capsuleDo not assume posterior capsule opacification explains every reduced postoperative acuity

Risk factors & context [1]

  • Record previous trauma or surgery, steroid exposure, diabetes, pseudoexfoliation and pupil dilation.
  • These findings affect surgical planning.

Complications [1]

  • Discuss individual risks of capsular rupture, infection, cystoid macular oedema and refractive surprise.
  • Later posterior capsule opacification can reduce vision again.

When to refer [1][2]

  • Pain and reduced vision after surgery require urgent exclusion of endophthalmitis or other complications.
References 2
  1. ESCRS · Recommendations for Cataract Surgery ↗2024 recommendations · online executive summary · 4.1 Patient selection; 4.2 Preoperative assessment; IOL selection; postoperative care
  2. RCOphth · Managing an outbreak of postoperative endophthalmitis ↗2022 · Recognition and initial management of suspected cases

European guidance. Drug availability and authorisations must be checked locally.

Evidence provenance

Evidence searched through
20 Sept 2026
Geographic applicability
European guidance. Drug availability and authorisations must be checked locally.
Version
fe291a631423
Guideline versions used
  • ESCRS · Recommendations for Cataract Surgery · 2024 recommendations · online executive summary
  • RCOphth · Managing an outbreak of postoperative endophthalmitis · 2022
View references →